Follow
Vaccine Research CAR T-Cells
Chimeric antigen receptors (CAR) T cells are a specialized therapy used as a cancer treatment in which a patient's immune cells are engineered to better identify and kill cancer cells. CAR T cell therapy can be effective for some types of leukemias and lymphomas but they also have the capacity to damage healthy calls, including B cells, the immune cells responsible for secreting antibodies. Many vaccines work by inducing your body to produce antibodies in response to a specific stimulus against which the vaccine is targeted. Therefore, studying how to maintain vaccine efficacy following CAR T cell therapy is an important research focus.
What's Popular in Vaccine Research CAR T-Cells
-
AUG 15, 2021Coronavirus
As Delta has become the dominant SARS-CoV-2 variant causing COVID-19 infections in the United States, researchers and he ...Written By: Carmen LeitchJAN 28, 2021Immunology
Natural killer cells, or NK cells, are specialized immune cells of the innate immune system. Their job revolves around e ...Written By: Tara FernandesDEC 27, 2020Immunology
Obesity is a significant problem in our societies with increasing the risk for many diseases, including cancer. Can ...Written By: Heba El-wassefJUN 07, 2020Cancer
New research published in Nature Communications suggests that the increased metabolism of T cells that we see with advan ...Written By: Kathryn DeMuth SullivanAPR 22, 2020Immunology
The best offense may be a good defense in the fight against COVID-19. Researchers from the Duke-NUS Medical School are e ...Written By: Kara Marker
AUG 15, 2021
Coronavirus
As Delta has become the dominant SARS-CoV-2 variant causing COVID-19 infections in the United States, researchers and he
...
Written By:
Carmen Leitch
JAN 28, 2021
Immunology
Natural killer cells, or NK cells, are specialized immune cells of the innate immune system. Their job revolves around e
...
Written By:
Tara Fernandes
DEC 27, 2020
Immunology
Obesity is a significant problem in our societies with increasing the risk for many diseases, including cancer. Can
...
Written By:
Heba El-wassef
JUN 07, 2020
Cancer
New research published in Nature Communications suggests that the increased metabolism of T cells that we see with advan
...
Written By:
Kathryn DeMuth Sullivan
APR 22, 2020
Immunology
The best offense may be a good defense in the fight against COVID-19. Researchers from the Duke-NUS Medical School are e
...
Written By:
Kara Marker
APR 18, 2019
Immunology
The C-word. Dare we say it? Is a cure for cancer within reach? Professor Michael Kinch https://publichealth.wustl
...
Written By:
Aleishia Harris-Arnold
MAR 12, 2019
Genetics & Genomics
It's been difficult to study infant development in detail, but new technology can change that.
Written By:
Carmen Leitch
MAR 06, 2019
Health & Medicine
There is a consensus that the first HIV infection occurred in the 1920s in Kinshasa, the Democratic Republic o
...
Written By:
Dena Aruta
FEB 12, 2019
Immunology
Scientists are uncovering the mechanisms behind recurring cases of step throat
Written By:
Nicholas Breehl
-
NOV 9 2022 | 8:00 AMC.E. CREDITS
Date: November 09, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) The field of cell and gene therapy is rapidly growing. In particular, the use of lentiviruses in CAR-T applications is...OCT 19 2022 | 1:30 PMC.E. CREDITS
COVID-19 remains a global health emergency with limited treatment options, lagging vaccine rates, and inadequate healthcare resources in the face of an ongoing calamity. The disease is chara...
OCT 12 2022 | 8:30 PM
C.E. CREDITS
Date: October 12, 2022, October 13, 2022 Time: 8:30pm (PDT), 11:30pm (EDT), 5:30am (CEST) High dimensional full spectrum flow cytometry holds the promise of addressing long-held questions in...
DEC 8 2021 | 8:00 AM
C.E. CREDITS
Date: December 08, 2021 Time: 8:00am (PDT), 11:00am (EDT) Learn how enrichment of primary dendritic cell (DC) subsets and sustainable DC manufacturing advances DC-based cell therapies. In th...
NOV 18 2021 | 8:00 AM
C.E. CREDITS
Date: November 18, 2021 Time: 8:00am (PDT), 11:00am (EDT) Keep ahead in CAR T and CAR NK cell research. We introduce advanced techniques for generating and characterizing engineered immune c...
NOV 9 2022 | 8:00 AM
C.E. CREDITS
Date: November 09, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) The field of cell and gene therapy is rapidly growing. In particular, the use of lentiviruses in CAR-T applications is...
OCT 19 2022 | 1:30 PM
C.E. CREDITS
COVID-19 remains a global health emergency with limited treatment options, lagging vaccine rates, and inadequate healthcare resources in the face of an ongoing calamity. The disease is chara...
OCT 12 2022 | 8:30 PM
C.E. CREDITS
Date: October 12, 2022, October 13, 2022 Time: 8:30pm (PDT), 11:30pm (EDT), 5:30am (CEST) High dimensional full spectrum flow cytometry holds the promise of addressing long-held questions in...
DEC 8 2021 | 8:00 AM
C.E. CREDITS
Date: December 08, 2021 Time: 8:00am (PDT), 11:00am (EDT) Learn how enrichment of primary dendritic cell (DC) subsets and sustainable DC manufacturing advances DC-based cell therapies. In th...
NOV 18 2021 | 8:00 AM
C.E. CREDITS
Date: November 18, 2021 Time: 8:00am (PDT), 11:00am (EDT) Keep ahead in CAR T and CAR NK cell research. We introduce advanced techniques for generating and characterizing engineered immune c...
NOV 3 2021 | 7:00 AM
C.E. CREDITS
Date: November 3, 2021 Time: 7:00am (PDT), 10:00am (EDT) The reconstitution of a fully functional human immune system in mouse after engraftment of purified hCD34+ hematopoietic cells provid...
OCT 7 2021 | 11:55 PM
C.E. CREDITS
Summary: Cancer neoantigens are highly specific to the tumor, potently immunogenic and can be targeted by both vaccines and engineered cellular therapies. This talk will introduce the defini...
JUL 27 2021 | 8:00 AM
C.E. CREDITS
Date: July 27, 2021 Time: 8:00am (PDT), 11:00am (EDT) The Origin of Biopharmaceutics (Biopharma) derive from The Division of Clinical Research in the U.S. Bureau of Medicine. However, author...
JUL 22 2021 | 12:45 PM
C.E. CREDITS
Gene editing technologies such as CRISPR/Cas9 have greater flexibility and high efficiency. CRISPR technology enables targeted insertion of transgenes at the desired locus and has the abilit...
-
NOV 02, 2022 | 5:30 AM PDTC.E. CREDITS
Labroots invites you to the 5th Annual Event in the CRISPR Virtual Event Series! This event will continue the conversation on the abilities of CRISPR-based editing, and much more....OCT 19, 2022 | 5:30 AM PDTC.E. CREDITS
Labroots announces the 2022 Coronavirus Virtual Event Series. A novel coronavirus emerged in China in 2019; it has since been dubbed COVID-19....OCT 04, 2022 | 5:30 AM PDTC.E. CREDITS
Labroots to host the 10th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This two day event will take place on October 4-6, 2022....JUL 28, 2022 | 8:00 AM PDT
GenScript is delighted to announce its 2nd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, lev...APR 19, 2022 | 5:30 AM PDTC.E. CREDITS
Labroots announces our 10th Annual Event in the Genetics Week Virtual Event Series on April 19-21, 2022! Genetics Week Virtual Event Series 2022 will offer a multi-day content-rich program....
NOV 02, 2022
| 5:30 AM PDT
C.E. CREDITS
Labroots invites you to the 5th Annual Event in the CRISPR Virtual Event Series! This event will continue the conversation on the abilities of CRISPR-based editing, and much more....
OCT 19, 2022
| 5:30 AM PDT
C.E. CREDITS
Labroots announces the 2022 Coronavirus Virtual Event Series. A novel coronavirus emerged in China in 2019; it has since been dubbed COVID-19....
OCT 04, 2022
| 5:30 AM PDT
C.E. CREDITS
Labroots to host the 10th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This two day event will take place on October 4-6, 2022....
JUL 28, 2022
| 8:00 AM PDT
GenScript is delighted to announce its 2nd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, lev...
APR 19, 2022
| 5:30 AM PDT
C.E. CREDITS
Labroots announces our 10th Annual Event in the Genetics Week Virtual Event Series on April 19-21, 2022! Genetics Week Virtual Event Series 2022 will offer a multi-day content-rich program....
FEB 23, 2022
| 5:30 AM PST
C.E. CREDITS
Labroots and the Drug Discovery planning committee are pleased to announce its 5th annual event in the Drug Discovery & Development Virtual Event Series....
OCT 06, 2021
| 5:30 AM PDT
C.E. CREDITS
Labroots and the Cancer Research and Oncology Planning Committee are pleased to announce the 9th Annual Event in the Cancer Research & Oncology Week Virtual Event Series!...
SEP 22, 2021
| 5:30 AM PDT
C.E. CREDITS
Labroots and the Cell Biology Planning Committee are pleased to announce the 5th Annual Event in the Cell Biology Virtual Event Series, providing an opportunity to...
SEP 08, 2021
| 6:00 AM PDT
Luminex's xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology uses color-coded microspheres as the substrate...